EA200001186A1 - Терапевтические комбинации (избирательных) модуляторов рецепторов эстрогенов (имрэ) и стимуляторов секреции гормона роста (ссгр) для лечения скелетно-мышечной слабости - Google Patents

Терапевтические комбинации (избирательных) модуляторов рецепторов эстрогенов (имрэ) и стимуляторов секреции гормона роста (ссгр) для лечения скелетно-мышечной слабости

Info

Publication number
EA200001186A1
EA200001186A1 EA200001186A EA200001186A EA200001186A1 EA 200001186 A1 EA200001186 A1 EA 200001186A1 EA 200001186 A EA200001186 A EA 200001186A EA 200001186 A EA200001186 A EA 200001186A EA 200001186 A1 EA200001186 A1 EA 200001186A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
electional
ssgr
imre
modulators
Prior art date
Application number
EA200001186A
Other languages
English (en)
Russian (ru)
Inventor
Хуа Жу Ки
Мей ЛИ
Лидия Кодетта Пэн
Дейвид Дуйэн Томпсон
Original Assignee
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.
Publication of EA200001186A1 publication Critical patent/EA200001186A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EA200001186A 1998-06-16 1999-06-16 Терапевтические комбинации (избирательных) модуляторов рецепторов эстрогенов (имрэ) и стимуляторов секреции гормона роста (ссгр) для лечения скелетно-мышечной слабости EA200001186A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8946998P 1998-06-16 1998-06-16
PCT/IB1999/001117 WO1999065486A1 (en) 1998-06-16 1999-06-16 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (1)

Publication Number Publication Date
EA200001186A1 true EA200001186A1 (ru) 2001-06-25

Family

ID=22217825

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200001186A EA200001186A1 (ru) 1998-06-16 1999-06-16 Терапевтические комбинации (избирательных) модуляторов рецепторов эстрогенов (имрэ) и стимуляторов секреции гормона роста (ссгр) для лечения скелетно-мышечной слабости

Country Status (30)

Country Link
EP (1) EP1087764A1 (de)
JP (1) JP2002518326A (de)
KR (1) KR20010052852A (de)
CN (1) CN1301160A (de)
AP (1) AP9901582A0 (de)
AR (1) AR018869A1 (de)
AU (1) AU4054799A (de)
BG (1) BG105041A (de)
BR (1) BR9911324A (de)
CA (1) CA2335134A1 (de)
CO (1) CO5070587A1 (de)
EA (1) EA200001186A1 (de)
GT (1) GT199900087A (de)
HN (1) HN1999000097A (de)
HR (1) HRP20000859A2 (de)
HU (1) HUP0102505A3 (de)
ID (1) ID27599A (de)
IL (1) IL138630A0 (de)
IS (1) IS5691A (de)
MA (1) MA26652A1 (de)
NO (1) NO20006312L (de)
OA (1) OA11505A (de)
PA (1) PA8475901A1 (de)
PE (1) PE20000646A1 (de)
PL (1) PL344981A1 (de)
SK (1) SK18912000A3 (de)
TN (1) TNSN99124A1 (de)
TR (1) TR200003544T2 (de)
WO (1) WO1999065486A1 (de)
ZA (1) ZA993975B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2360103A1 (en) * 1999-02-08 2000-08-17 Robert Sladek Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha
EP1156120B1 (de) 2000-05-08 2006-11-22 Pfizer Products Inc. Enzymatische Spaltung von selektiven Modulatoren des Östrogenrezeptors
EP1313473A2 (de) * 2000-08-30 2003-05-28 Pfizer Products Inc. Arzneizusammensetzungen mit verzögerter wirkstoffabgabe für wachstumshormonsekretionsförderer
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) * 2004-08-31 2006-03-09 Pfizer Products Inc. Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
KR20090107088A (ko) 2007-02-09 2009-10-12 트랜자임 파르마 인크 거대고리 그렐린 수용체 조절제 및 이의 사용 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
HUP0102505A2 (hu) 2001-11-28
IL138630A0 (en) 2001-10-31
ZA993975B (en) 2000-12-15
PE20000646A1 (es) 2000-08-05
NO20006312D0 (no) 2000-12-12
SK18912000A3 (sk) 2001-10-08
NO20006312L (no) 2000-12-12
AR018869A1 (es) 2001-12-12
AU4054799A (en) 2000-01-05
GT199900087A (es) 2000-12-07
CO5070587A1 (es) 2001-08-28
HN1999000097A (es) 1999-11-03
CN1301160A (zh) 2001-06-27
OA11505A (en) 2004-05-07
TNSN99124A1 (fr) 2005-11-10
KR20010052852A (ko) 2001-06-25
BG105041A (en) 2001-08-31
BR9911324A (pt) 2001-04-03
MA26652A1 (fr) 2004-12-20
TR200003544T2 (tr) 2001-04-20
CA2335134A1 (en) 1999-12-23
EP1087764A1 (de) 2001-04-04
ID27599A (id) 2001-04-12
JP2002518326A (ja) 2002-06-25
HUP0102505A3 (en) 2002-12-28
IS5691A (is) 2000-10-27
AP9901582A0 (en) 1999-06-30
PL344981A1 (en) 2001-11-19
WO1999065486A1 (en) 1999-12-23
HRP20000859A2 (en) 2001-04-30
PA8475901A1 (es) 2000-05-24

Similar Documents

Publication Publication Date Title
DE60037836D1 (de) ThiazoloÄ4,5-dÜpyrimidinverbindungen zur Behandlung von rheumathoider Arthritis
IL165262A (en) Kinase inhibitors and pharmaceutical compositions containing them
LU91145I2 (fr) FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX).
NO20052219L (no) Fremgangsmater for behandling av postkirurgisk smerte ved administrering av en nervevekstfaktorantagonist og preparater inneholdende dette
NO990663D0 (no) Substituerte pyrimidinderivater og deres farmas°ytiske anvendelse
MY106407A (en) N-(3-hydroxy-4-piperidinyl)(dihydrobenzo-furan, dihydro-2h-benzopyran or dihydro-benzodioxin) carboxamide derivatives.
WO2002060392A3 (en) Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
EA200001186A1 (ru) Терапевтические комбинации (избирательных) модуляторов рецепторов эстрогенов (имрэ) и стимуляторов секреции гормона роста (ссгр) для лечения скелетно-мышечной слабости
AP9901580A0 (en) Therapeutic combination comprising a selective estrogen receptor modulator and parathyroid hormone.
EA200001189A1 (ru) Терапевтические комбинации (избирательных) модуляторов рецепторов эстрогенов (имрэ) и стимуляторов секреции гормона роста (ссгр) для лечения скелетно-мышечной слабости
NZ504051A (en) Crystalline polymorphs of 1,3-di-cyclopropylmethyl-8-amino xanthine (cypamfylline), and the use of these compounds for treating PDE4 or TNF mediated diseases
YU60803A (sh) Upotreba antagonista gal3 receptora u lečenju depresije i/ili uznemirenosti i jedinjenja korisna u tim postupcima
DE69916932D1 (de) Kombinationstherapeutika, enthaltend einen selektiven Östrogenrezeptormodulator und Prostaglandin E2
ECSP993021A (es) Combinaciones terapeuticas para la fragilidad musculoesqueletica
RU1805984C (ru) Способ лечени больных с осложненными переломами трубчатых костей
ECSP993020A (es) Terapia de combinacion para la fragilidad musculoesqueletica
UA40196A (uk) Спосіб хірургічного лікування переломовивиху проксимального кінця плечової кістки